Stocks · Health care · Surgical & Medical Instruments & Apparatus

Pulmonx Corp

LUNG Clue Score49
United States Fiscal year ends December CIK 0001127537 Results filed 27 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Geoffrey Beran Rose
1 Sep 2026
Chief Commercial Officer
Sell
1,746
$2.26
$3.95K
Geoffrey Beran Rose
1 Sep 2026
Chief Commercial Officer
Sell
1,530
$2.26
$3.46K
Geoffrey Beran Rose
1 Sep 2026
Chief Commercial Officer
Sell
2,390
$2.26
$5.40K
Geoffrey Beran Rose
1 Sep 2026
Chief Commercial Officer
Sell
2,213
$2.26
$5.00K
David Aaron Lehman
1 Sep 2026
General Counsel
Sell
4,827
$2.26
$10.91K
David Aaron Lehman
1 Sep 2026
General Counsel
Sell
3,476
$2.26
$7.86K
David Aaron Lehman
1 Sep 2026
General Counsel
Sell
2,224
$2.26
$5.03K
David Aaron Lehman
1 Sep 2026
General Counsel
Sell
3,807
$2.26
$8.60K
Srikanth Radhakrishnan
1 Sep 2026
Chief Science & Techn. Officer
Sell
5,863
$2.26
$13.25K
Srikanth Radhakrishnan
1 Sep 2026
Chief Science & Techn. Officer
Sell
3,618
$2.26
$8.18K
Srikanth Radhakrishnan
1 Sep 2026
Chief Science & Techn. Officer
Sell
2,121
$2.26
$4.79K
Srikanth Radhakrishnan
1 Sep 2026
Chief Science & Techn. Officer
Sell
2,643
$2.26
$5.97K
Glendon E. French III
1 Sep 2026
President and CEO
Sell
37,784
$2.26
$85.39K
Glendon E. French III
1 Sep 2026
President and CEO
Sell
4,098
$2.26
$9.26K
Glendon E. French III
2 Jun 2026
President and CEO
Sell
13,511
$1.57
$21.21K
Glendon E. French III
1 Jun 2026
President and CEO
Sell
38,467
$1.54
$59.24K
Glendon E. French III
1 Jun 2026
President and CEO
Sell
4,171
$1.54
$6.42K
Geoffrey Beran Rose
1 Jun 2026
Chief Commercial Officer
Sell
2,254
$1.54
$3.47K
Geoffrey Beran Rose
1 Jun 2026
Chief Commercial Officer
Sell
2,434
$1.54
$3.75K
Geoffrey Beran Rose
1 Jun 2026
Chief Commercial Officer
Sell
1,557
$1.54
$2.40K
Geoffrey Beran Rose
1 Jun 2026
Chief Commercial Officer
Sell
1,778
$1.54
$2.74K
David Aaron Lehman
1 Jun 2026
General Counsel
Sell
4,915
$1.54
$7.57K
David Aaron Lehman
1 Jun 2026
General Counsel
Sell
3,539
$1.54
$5.45K
David Aaron Lehman
1 Jun 2026
General Counsel
Sell
2,264
$1.54
$3.49K
David Aaron Lehman
1 Jun 2026
General Counsel
Sell
3,876
$1.54
$5.97K
Srikanth Radhakrishnan
1 Jun 2026
Chief Science &Techn. Officer
Sell
5,969
$1.54
$9.19K
Srikanth Radhakrishnan
1 Jun 2026
Chief Science &Techn. Officer
Sell
3,684
$1.54
$5.67K
Srikanth Radhakrishnan
1 Jun 2026
Chief Science &Techn. Officer
Sell
2,153
$1.54
$3.32K
Srikanth Radhakrishnan
1 Jun 2026
Chief Science &Techn. Officer
Sell
2,691
$1.54
$4.14K
David Aaron Lehman
2 Mar 2026
General Counsel
Sell
4,051
$1.43
$5.79K
David Aaron Lehman
2 Mar 2026
General Counsel
Sell
2,590
$1.43
$3.70K
David Aaron Lehman
2 Mar 2026
General Counsel
Sell
4,433
$1.43
$6.34K
David Aaron Lehman
2 Mar 2026
General Counsel
Sell
1,163
$1.43
$1.66K
Geoffrey Beran Rose
2 Mar 2026
Chief Commercial Officer
Sell
2,911
$1.43
$4.16K
Geoffrey Beran Rose
2 Mar 2026
Chief Commercial Officer
Sell
1,861
$1.43
$2.66K
Geoffrey Beran Rose
2 Mar 2026
Chief Commercial Officer
Sell
2,125
$1.43
$3.04K
Geoffrey Beran Rose
2 Mar 2026
Chief Commercial Officer
Sell
835
$1.43
$1.19K
Glendon E. French III
2 Mar 2026
President and CEO
Sell
58,368
$1.43
$83.47K
Glendon E. French III
2 Mar 2026
President and CEO
Sell
6,737
$1.43
$9.63K
Glendon E. French III
2 Mar 2026
President and CEO
Sell
2,708
$1.43
$3.87K
Srikanth Radhakrishnan
2 Mar 2026
Chief Science &Techn. Officer
Sell
4,198
$1.43
$6.00K
Srikanth Radhakrishnan
2 Mar 2026
Chief Science &Techn. Officer
Sell
2,461
$1.43
$3.52K
Srikanth Radhakrishnan
2 Mar 2026
Chief Science &Techn. Officer
Sell
3,068
$1.43
$4.39K
Srikanth Radhakrishnan
2 Mar 2026
Chief Science &Techn. Officer
Sell
756
$1.43
$1.08K
Daniel P Florin
8 Dec 2025
Director
Sold on a plan
23,321
$1.99
$46.41K
David Aaron Lehman
1 Dec 2025
General Counsel
Sell
3,401
$1.57
$5.34K
David Aaron Lehman
1 Dec 2025
General Counsel
Sell
2,176
$1.57
$3.42K
David Aaron Lehman
1 Dec 2025
General Counsel
Sell
3,725
$1.57
$5.85K
David Aaron Lehman
1 Dec 2025
General Counsel
Sell
976
$1.57
$1.53K
Geoffrey Beran Rose
1 Dec 2025
Chief Commercial Officer
Sell
2,379
$1.57
$3.74K
Geoffrey Beran Rose
1 Dec 2025
Chief Commercial Officer
Sell
1,522
$1.57
$2.39K
Geoffrey Beran Rose
1 Dec 2025
Chief Commercial Officer
Sell
1,738
$1.57
$2.73K
Geoffrey Beran Rose
1 Dec 2025
Chief Commercial Officer
Sell
683
$1.57
$1.07K
Glendon E. French III
1 Dec 2025
President and CEO
Sell
6,281
$1.57
$9.86K
Glendon E. French III
1 Dec 2025
President and CEO
Sell
2,524
$1.57
$3.96K

What was left out

Form 4 filings counted 23
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 0
Sales at will 54
Transactions with no price 0
Shares from compensation/vesting 3,065,000
History held since 2 Oct 2020